Advertisement
Home »

Evolution of atrophied T2 lesion volume in primary-progressive multiple sclerosis: results from the phase 3 ORATORIO study.

Dec 11, 2023

ABOUT THE EXPERTS

  • Robert Zivadinov

    Buffalo Neuroimaging Analysis Center, Department of Neurology, Jacobs School of Medicine and Biomedical Sciences, University at Buffalo, State University of New York, Buffalo, NY, USA Rzivadinov@bnac.net.

    Center for Biomedical Imaging at Clinical Translational Science Institute, University at Buffalo, State University of New York, Buffalo, NY, USA.

    Jinglan Pei

    Genentech Inc, South San Francisco, CA, USA.

    David Clayton

    Genentech Inc, South San Francisco, CA, USA.

    Donna E Goldman

    Genentech Inc, South San Francisco, CA, USA.

    Ryan C Winger

    Genentech Inc, South San Francisco, CA, USA.

    Mark S Cabatingan

    Genentech Inc, South San Francisco, CA, USA.

    Michael G Dwyer

    Buffalo Neuroimaging Analysis Center, Department of Neurology, Jacobs School of Medicine and Biomedical Sciences, University at Buffalo, State University of New York, Buffalo, NY, USA.

    Center for Biomedical Imaging at Clinical Translational Science Institute, University at Buffalo, State University of New York, Buffalo, NY, USA.

    Niels Bergsland

    Buffalo Neuroimaging Analysis Center, Department of Neurology, Jacobs School of Medicine and Biomedical Sciences, University at Buffalo, State University of New York, Buffalo, NY, USA.

REFERENCES & ADDITIONAL READING

PubMed

MORE ARTICLES BELOW

PW Weekly Newsletters

The latest articles and insights from your colleagues in your specialty(ies) of choice.


Advertisement
Advertisement
ad
ad
MORE ARTICLES BELOW

PW Weekly Newsletters

The latest articles and insights from your colleagues in your specialty(ies) of choice.

SUBSCRIBE NOW

View all newsletters

Advertisement